share_log

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

JMP证券维持Ocular Therapeutix的市场跑赢大盘,将目标股价下调至22美元
Benzinga ·  05/08 14:08

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $24 to $22.

JMP证券分析师乔纳森·沃勒本维持Ocular Therapeutix(纳斯达克股票代码:OCUL)的市场表现跑赢大盘,并将目标股价从24美元下调至22美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发